What To Expect From Menopause?

Updated Dec 14, 2024 | 01:00 AM IST

SummaryNavigating menopause isn’t just about hormonal changes—it’s about understanding your body’s new rhythm. Discover how to manage weight gain effectively and embrace this life phase with confidence.
Menopause could lead to weight gain

Menopause could lead to weight gain (Credits: Canva)

There are many phases in a woman's life, menarche, menstruations, pregnancy, postpartum and menopause. Each phase comes with its own challenges, and changes the way of looking at life. However, narrowing to one, today we are focusing on weight gain after menopause. Gaining weight is a common concern for many women are approaching menopause. This period brings hormonal changes, shifts in activity levels and effects of aging. All of these contribute to weight gain. However, not everyone experiences weight gain during menopause, and individual experiences may vary greatly.

Menopause and Its Life Phases

Before diving into the specifics of weight gain, it’s helpful to understand the terminology associated with menopause:

  • Premenopause refers to the period between puberty and the commencement of perimenopause.
  • Perimenopause is the transitory period before menopause, characterized by fluctuating reproductive hormones.
  • Menopause is defined as the absence of menstrual cycles for 12 consecutive months.
  • Postmenopause is the period following menopause; typically used interchangeably with "menopause."

Hormonal Changes and Weight Gain

Hormones influence weight fluctuations after menopause, specifically how fat is distributed and how the body controls hunger.

Fat Content and Distribution

The hormonal fluctuations of perimenopause and menopause influence where fat is stored in the body:

Perimenopause: During this phase, estrogen levels fluctuate while progesterone levels decline steadily. In early perimenopause, higher estrogen levels can promote fat storage in the hips and thighs as subcutaneous fat, which generally carries fewer health risks.

Menopause: As estrogen levels drop significantly, fat storage shifts to the abdominal area as visceral fat.

This type of fat surrounds internal organs and is associated with health risks like:

  • Insulin resistance
  • Type 2 diabetes
  • Heart disease
  • Other metabolic issues

Appetite Regulation

Lower estrogen levels during perimenopause can have an impact on appetite management. A 2019 analysis found that decreased estrogen may diminish satiety signals, making you feel less full after meals. This might lead to increased calorie consumption and weight gain.

The Effect of Age on Weight

Weight gain during menopause is attributed to more than just hormonal changes. Several elements come into play throughout the aging process:

Increased fat content and decreased muscle mass: These changes affect the body's resting energy expenditure (REE), which means fewer calories are expended when at rest.

Lower activity levels: Fatigue, sleep difficulties, and menopause-related symptoms can all lead to a decrease in physical activity, further reducing REE and increasing weight.

Managing Weight Gain During Menopause

If you are concerned about weight gain during menopause, a variety of strategies can help you manage it effectively. It is usually recommended that you speak with a healthcare practitioner before developing a specific approach.

Dietary modifications

Focus on a well-balanced diet that includes less carbohydrates, more fiber, and less added sugar and salt.

Include nutrient-dense meals to boost overall health.

Physical exercise

Regular exercise helps to maintain muscle mass and reduce body fat. Strength training, aerobic, and flexibility exercises are quite beneficial.

If you have osteoporosis, see your doctor about safe activity options.

Rest and Stress Management

Prioritize sleep and relaxation to combat fatigue and stress, both of which can contribute to weight gain.

Mindfulness practices or yoga may help reduce stress levels.

End of Article

Breast Cancer Patients Choosing Alternative Medicine Face Higher Death Risk | Women's Day

Updated Mar 8, 2026 | 06:16 PM IST

SummaryResearchers from Yale University School of Medicine have now found that those who undergo CAM have over three times higher risk of death than those who receive standard therapy. Using CAM alongside standard treatment was linked to a 45 percent higher risk of death
Breast Cancer Patients Choosing Alternative Medicine Face Higher Death Risk | Women's Day

Credit: Canva

Breast cancer patients who chose to undergo complementary and alternative medicine treatments have the lowest survival rates, a JAMA Oncology study shows.

This form of cancer continues to be the most common cancer among women worldwide, and predicted that the number of new cases of the deadly disease will reach more than 3.5 million globally in 2050 -- rising by a third from 2.3 million in 2023.

The Global Burden of Disease analysis with data from 204 countries revealed that despite advancements in breast cancer treatments, yearly deaths from the disease will rise by 44 percent, from 764,000 to 1.4 million.

About 1.9 lakh Indian women are diagnosed with breast cancer annually, meaning that a new case is diagnosed every four minutes. On average, a woman in India dies of breast cancer every eight minutes, highlighting how urgently the country needs stronger awareness, early diagnosis and sustained care.

One factor that sets India apart is the age at which women are affected. Almost half of all breast cancer patients in the country are younger than 45. This is a much higher proportion than seen in many Western nations, where the disease is usually detected later in life.

Despite multiple advancements in therapies to cure breast cancer, including surgery, chemotherapy, radiation, endocrine therapy, and immunotherapy, a subset of patients continues to choose complementary and alternative medicine (CAM).

However, researchers from Yale University School of Medicine have now found that those who undergo CAM have over three times higher risk of death than those who receive standard therapy.

CAM consists of healthcare practices, products and therapies not generally considered part of conventional Western medicine such as herbal products, vitamins, minerals, meditation, acupuncture, hypnotherapy, tai chi, Reiki and guided imagery.

Using CAM alongside standard treatment was linked to a 45 percent higher risk of death compared with using standard treatment alone, the study noted.

Additionally, women who combined CAM with standard treatment were also less likely to receive key therapies such as hormone therapy or radiation, which worsened their chances of survival and recovery.

What Leads To Breast Cancer?

In 2023, 28 percent of the global breast cancer burden (6.8 million years of healthy life lost to disability, illness, and early death) was linked to six potentially modifiable risk factors. These include:

  • High red meat consumption -- linked to nearly 11 percent of all healthy life lost
  • tobacco use (including second-hand smoke; 8 percent),
  • high blood sugar (6 percent),
  • high body mass index (4 percent),
  • high alcohol use and low physical activity (both 2 percent)

Substantial progress has been made in reducing the global breast cancer burden linked to high alcohol use and tobacco between 1990 and 2023, which declined by 47 percent and 28 percent, respectively.

Can AI Help With Earlier Detection?

Using artificial intelligence (AI) in breast cancer screening can reduce the number of cancers diagnosed in late stages by 12 percent, according to a major new study from Sweden.

The study found that fewer women in the AI group were diagnosed with breast cancer in the years after screening. There were 1.55 cancers per 1,000 women in the AI-supported group, compared with 1.76 per 1,000 in the standard screening group.

According to lead author Dr Kristina Lang of Lund University in Sweden, this indicates better early identification of clinically relevant cancers. She said of the results: “Our findings show that AI-supported screening improves the early detection of breast cancers that are more likely to become aggressive or advanced.

“This results in fewer serious cancers being diagnosed in the interval between screenings.”

She added that wider adoption of AI-supported mammography could ease workforce pressures on radiologists while improving early detection, including of aggressive cancer subtypes.

End of Article

Cervical Cancer Screening: Clinic vs Home Testing, What Women Prefer | Women's Day

Updated Mar 8, 2026 | 04:19 PM IST

SummaryA new JAMA study shows over 60 percent preferred clinic-based testing, 20 percent preferred at-home self-sampling tests and over 18 percent were unsure. However, women who had experienced prejudice or discrimination in healthcare were nearly twice as likely to prefer at-home testing
Cervical Cancer Screening: Clinic vs Home Testing, What Women Prefer | Women's Day

As cervical cancer screenings ramp up across the world, a new JAMA study shows that a majority of women prefer clinic-based testing over at-home self-sampling tests in the US.

Researchers from the University of Texas MD Anderson Cancer Center, Houston studied 2,300 women with an average age of 45.5 years. Most were married or living with a partner (58.2 percent), had health insurance (91.9 percent), and had at least some college education (61.6 percent).

Out of those analyzed, over 60 percent preferred clinic-based testing, 20 percent preferred at-home self-sampling tests and over 18 percent were unsure. However, women who had experienced prejudice or discrimination in healthcare were nearly twice as likely to prefer at-home testing.

The study noted that out of the women who preferred at-home testing, nearly 55 percent said it was due to greater privacy, over 35 percent said it was because of a lack of time and over 33 percent noted it was due to fear of embarrassment.

Marginalized women, individuals with low income and individuals who do not trust the health care system were also more likely to prefer at-home self-sampling for cervical cancer screening or not know which option to choose.

To increase screening uptake, the researchers suggested that US officials should incorporate home-based self-sampling as an alternative to clinic-based testing, women’s education and empowerment should be enhanced and tailored interventions focusing on high-risk groups are needed to increase awareness and self-confidence in performing home-based self-sampling.

What Is Cervical Cancer?

Cervical cancer develops in a women's cervix (uterus opening) due to abnormal cell growth, primarily caused by persistent HPV infection, a common infection that's passed through sexual contact.

When exposed to HPV, the body's immune system typically prevents the virus from causing damage however, in a small percentage of people, the virus can survive for years and pave the way for some cervical cells to become cancerous.

Treatment involves surgery, radiation, and chemotherapy, with early detection significantly improving outcomes, though it remains a major cancer in low-income countries Cervical cancer can also be prevented through vaccination and regular screening (Pap/HPV tests).

Symptoms Of Cervical Cancer

Cervical cancer has no symptoms in the early days and therefore, is hard to detect until it has spread. However, the early-stage symptoms include:

  • Vaginal bleeding after sex
  • Vaginal bleeding post-menopause
  • Vaginal bleeding between periods or unusually heavy/long periods
  • Watery vaginal discharge with a strong odour or containing blood
  • Pelvic pain or pain during intercourse
  • Advanced Cervical Cancer Symptoms (when cancer has spread beyond the cervix)
  • Painful or difficult bowel movements or rectal bleeding
  • Painful or difficult urination or blood in the urine
  • Persistent dull backache
  • Swelling of the legs
  • Pain in the pelvis or lower abdomen

Cervical Cancer: A Growing Crisis In India

Despite being highly preventable as well as treatable, cervical cancer is a public health concern in India.

As per the World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus, about 42,000 new cases of cervical cancer is reported annually in India. This underscores the need for preventive measures such as vaccination and early screening. The country loses one women every eight minutes to cervical cancer.

The WHO Global Strategy to eliminate cervical cancer includes the 90-70-90 targets by 2030 -- vaccinating 90 per cent of girls against HPV, screening 70 percent of women, and ensuring treatment for 90 percent of those diagnosed with cervical disease.

In line with the global strategy to fight cervical cancer, Prime Minister Narendra Modi recently also launched a free HPV vaccination drive that will target health and well-being of adolescent girls in the country.

Union Health Minister JP Nadda has also announced that cervical cancer screenings using Visual Inspection with Acetic Acid (VIA) will now be available at Ayushman Arogya Mandirs and other health facilities for women between 30 and 65 years of age.

"Screening for cervical cancer is now available at 1,81,000 Ayushman Arogya Mandirs, also known as Health and Wellness Centers, across the country as a part of population based screening for early detection and treatment," said Nadda, while addressing a press briefing at the World Health Organization virtually.

Using VIA, a low-cost, point-of-care method, trained health workers will screen women for cervical cancer. Those who test positive will then be referred to higher centers for diagnostic confirmation and further evaluation.

End of Article

Viagra Is The Best Existing Treatment For Alzheimer's Disease, Scientists Say

Updated Mar 8, 2026 | 02:39 PM IST

SummaryViagra, a popular erectile dysfunction medication, may be the world's only existing treatment against Alzheimer's disease, according to over 20 experts. Previous research also shows that the compound can lower markers of brain inflammation. Additionally, it can also protect neurons from amyloid-beta damage
Viagra Is The Best Existing Treatment For Alzheimer's Disease, Scientists Say

Credit: Canva

Viagra, a popular erectile dysfunction medication, may be the world's only existing treatment against Alzheimer's disease, according to over 20 experts.

A panel of 21 experts recently combed through anonymous nominations, clinical evidence and found that out of 80 existing medications that show potential in treating the neurodegenerative disorder.

Out of those, Sildenafil (Viagra) ranked first, with Zostavax (a shingles vaccine) and Riluzole (a drug used to treat amyotrophic lateral sclerosis) coming in second and third.

"Each of the priority candidates has evidence supporting relevant underlying mechanisms of action, non-clinical studies, and clinical evidence from epidemiological studies and/or preliminary clinical trials," the researchers wrote in their paper.

"The tolerability of each of these compounds is also suitable for administration to a frailer population of older individuals as part of a well-monitored clinical trial program. We therefore recommend each of these therapeutic approaches as a high priority for clinical trials for the treatment or prevention of Alzheimer's disease."

The researchers found that Viagra may support brain health in several ways. Studies suggest it can promote the growth of nerve extensions (neurites) and reduce abnormal tau protein activity as well as improve blood flow and oxygen supply to the brain.

Previous research also shows that the compound can reduce levels of amyloid-beta (Aβ42) in the hippocampus and lower markers of brain inflammation. Additionally, it can also protect neurons from amyloid-beta damage.

Scientists are yet to determine the exact mechanism behind how Viagra can help protect the brain from Alzheimer's-related damage.

What Is Alzheimer’s Disease?

Alzheimer's disease is one of the most common forms of dementia and mostly affects adults over the age of 65.

About 8.8 million Indians aged 60 and above are estimated to be living with Alzheimer's disease. Over seven million people in the US 65 and older live with the condition and over 100,00 die from it annually.

Alzheimer's disease is believed to be caused by the development of toxic amyloid and beta proteins in the brain, which can accumulate in the brain and damage cells responsible for memory.

Amyloid protein molecules stick together in brain cells, forming clumps called plaques. At the same time, tau proteins twist together in fiber-like strands called tangles. The plaques and tangles block the brain's neurons from sending electrical and chemical signals back and forth.

Over time, this disruption causes permanent damage in the brain that leads to Alzheimer's disease and dementia, causing patients to lose their ability to speak, care for themselves or even respond to the world around them.

While there is no clear cause of Alzheimer's disease, experts believe it can develop due to genetic mutations and lifestyle choices, such as physical inactivity, unhealthy diet and social isolation.

Early symptoms of Alzheimer's disease include forgetting recent events or conversations. Over time, Alzheimer's disease leads to serious memory loss and affects a person's ability to do everyday tasks.

There is no cure for this progressive brain disorder and in advanced stages, loss of brain function can cause dehydration, poor nutrition or infection. These complications can result in death.

Can You Detect Alzheimer's Early On?

The US Food and Drug Administration has approved the use of a blood test which can help diagnose Alzheimer’s disease in adults aged 55 and above.

The blood test, known as Lumipulse, can detect amyloid plaques associated with Alzheimer’s disease and has proven to be a “less invasive option” that “reduces reliance on PET scans and increases diagnosis accessibility.”

FDA Commissioner Martin A. Makary said of the landmark decision, "Alzheimer’s disease impacts too many people, more than breast cancer and prostate cancer combined.

"Knowing that 10 percent of people aged 65 and older have Alzheimer's, and that by 2050 that number is expected to double, I am hopeful that new medical products such as this one will help patients."

It remains unclear when this test will be available for commercial use across the world.

End of Article